Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with donepezil and rivastigmine

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 4, 2009, Pages 502-507

  Scacchi, Renato ^a   Gambina, Giuseppe ^b   Moretto, Giuseppe ^b   Corbo, Rosa Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

Author keywords

Cholinergic system; Cholinesterase inhibitors; SNP

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE; DONEPEZIL; RIVASTIGMINE;

ACHE GENE; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BCHE GENE; CHAT GENE; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDANS; MALE; MIDDLE AGED; PHENYLCARBAMATES; PIPERIDINES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 66649095353     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30846     Document Type: Article

References (19)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington D.C: American Psychiatric Association.
2. Bartus RT, Dean RL III, Beer B, Lippa AS. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-417. (Pubitemid 12048290)
3. Blesa R, Bullock R, He Y, Bergman H, Gambina G, Meyer J, Rapatz G, Nagel J, Lane R. 2006. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease. Pharmacogenet Genomics 16:771-774. (Pubitemid 44632290)
4. Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, Xuereb J, Cairns NJ, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Williams J, Rubinsztein DC. 2005. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet Part B 132B:5-8. (Pubitemid 40066186)
5. Folstein MF, Folstein SE. McHugh PR: "Mini-mental state". 1975. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189-198.
6. Francis PT, Palmer AM, Snape M, Wilcock GK. 1999. The cholinergic hypothesis of Alzheimer's disease: A review of progress. J Neurol Neurosurg Psychiatry 66:137-147. (Pubitemid 29103513)
7. Giacobini E. 1994. The second generation of cholinesterase inhibitors: Pharmacologic aspects. In: Giacobini E, Becker R, editors. Alzheimer's disease. Therapeutic strategies. Boston: Birkhauser. pp 247-262.
8. Griffith P, Lichtenberg P, Goldman R, Payne-Parrish J. 2006. Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease. J Natl Med Assoc 98:1590-1597. (Pubitemid 44682951)
9. Hutton M, Hardy J. 1997. The presenilins and Alzheimer's disease. Hum Mol Genet 6:639-1646. (Pubitemid 27401606)
10. Lehmann DJ, Williams J, McBroom J, Smith AD. 2001. Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 108:541-554. (Pubitemid 33660714)
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944. (Pubitemid 14076461)
12. Panza F, D'Introno A, Colacicco AM, Basile AM, Capurso C, Kehoe PG, Capurso A, Solfrizzi V. 2004. Vascular risk and genetics of sporadic lateonset Alzheimer's Disease. J Neural Transm 111:69-89. (Pubitemid 38177819)
13. Piccardi M, Congiu D, Squassina A, Manconi F, Putzu PF, Mereu RM, Chillotti C, Del Zompo M. 2007. Alzheimer's disease: Case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. Am J Med Genet Part B 144B:895-899. (Pubitemid 47547990)
14. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak- Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472. (Pubitemid 23230526)
15. Scacchi R, Ruggeri M, Gambina G, Martini MC, Ferrari G, Corbo RM. 2001. Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes. Neurobiol Aging 22:413-416. (Pubitemid 32510913)
16. St George-Hyslop PH. 2000. Molecular genetics of Alzheimer disease. Biol Psychiatry 47:183-199.
17. Terwilliger JD, Ott J. 1994. Linkage disequilibrium and disease loci. In: Handbook for human genetic linkage. Baltimore: Johns Hopkins University. pp 199-210.
18. Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N. 1999. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur J Hum Genet 7:659-663. (Pubitemid 29424056)
19. Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG. 2004. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: A meta-analysis of individual patient data from randomized controlled trials. Int J Geriatr Psychiatry 19:624-633. (Pubitemid 38996839)